Divergent effect of proteasome inhibition on interleukin-1β and tumor necrosis factor α signaling in human astroglial cells

FEBS Letters

Volumn 581, Issue 24, 2007, Pages 4691-4696

  Choi, Kyungsun ^a   Lee, Jungsul ^a   Choi, Chulhee ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Astrocyte; Chemokine; Inflammation; JNK; NF B; Proteasome

Indexed keywords

CHEMOKINE; I KAPPA B ALPHA; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PROTEASOME; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL;

APOPTOSIS; ASTROCYTES; CASPASES; CELLS, CULTURED; CHEMOKINES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE KINASES; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548674948     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.08.065     Document Type: Article

References (21)

1. Ross C.A., and Poirier M.A. Opinion: What is the role of protein aggregation in neurodegeneration?. Nat. Rev. Mol. Cell Biol. 6 (2005) 891-898
2. Bradbury J. Proteolysis problems implicated in neurodegenerative diseases. Lancet 357 (2001) 1679
3. Keller J.N., Hanni K.B., and Markesbery W.R. Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75 (2000) 436-439
4. Layfield R., Alban A., Mayer R.J., and Lowe J. The ubiquitin protein catabolic disorders. Neuropathol. Appl. Neurobiol. 27 (2001) 171-179
5. Nakayama K., Furusu A., Xu Q., Konta T., and Kitamura M. Unexpected transcriptional induction of monocyte chemoattractant protein 1 by proteasome inhibition: involvement of the c-jun N-terminal kinase-activator protein 1 pathway. J. Immunol. 167 (2001) 1145-1150
6. Rockwell P., Yuan H., Magnusson R., and Figueiredo-Pereira M.E. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2). Arch. Biochem. Biophys. 374 (2000) 325-333
7. Duffey D.C., Chen Z., Dong G., Ondrey F.G., Wolf J.S., Brown K., Siebenlist U., and Van Waes C. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res. 59 (1999) 3468-3474
8. Hosseini H., Andre P., Lefevre N., Viala L., Walzer T., Peschanski M., and Lotteau V. Protection against experimental autoimmune encephalomyelitis by a proteasome modulator. J. Neuroimmunol. 118 (2001) 233-244
9. Choi C., Kutsch O., Park J.S., Zhou T., Seol D.W., and Benveniste E.N. Tumor necrosis factor related apoptosis inducing ligand (TRAIL) induces caspase-dependent Interleukin-8 expression and apoptosis in human astroglioma cells. Mol. Cell Biol. 22 (2002) 724-736
10. Choi C., et al. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J. Immunol. 162 (1999) 1889-1895
11. Choi C., Xu X., Oh J.W., Lee S.J., Gillespie G.Y., Park H., Jo H., and Benveniste E.N. Fas-induced expression of chemokines in human glioma cells: involvement of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Cancer Res. 61 (2001) 3084-3091
12. Takaesu G., Surabhi R.M., Park K.J., Ninomiya-Tsuji J., Matsumoto K., and Gaynor R.B. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J. Mol. Biol. 326 (2003) 105-115
13. Xia Z.P., and Chen Z.J. TRAF2: a double-edged sword?. Sci. STKE 2005 (2005) pe7
14. Ea C.K., Sun L., Inoue J., and Chen Z.J. TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc. Natl. Acad. Sci. USA 101 (2004) 15318-15323
15. Li X., Yang Y., and Ashwell J.D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416 (2002) 345-347
16. Jones R.W. Inflammation and Alzheimer's disease. Lancet 358 (2001) 436-437
17. Bondeson J., Browne K.A., Brennan F.M., Foxwell B.M., and Feldmann M. Selective regulation of cytokine induction by adenoviral gene transfer of IkappaBalpha into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-kappaB independent. J. Immunol. 162 (1999) 2939-2945
18. Matsusaka T., Fujikawa K., Nishio Y., Mukaida N., Matsushima K., Kishimoto T., and Akira S. Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc. Natl. Acad. Sci. USA 90 (1993) 10193-10197
19. 2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells. J. Biol. Chem. 273 (1998) 32670-32678
20. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., and Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17 (1999) 331-367
21. Rieder J., Jahnke R., Schloesser M., Seibel M., Czechowski M., Marth C., and Hoffmann G. Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines. Gynecol. Oncol. 82 (2001) 172-176